Charles W Moorman bought $948K of Oracle (ORCL)
Executed Feb 12 2025, disclosed Feb 14 2025, 2 days later.
Over the 21 trading sessions from the disclosed entry session (Feb 14 2025), the stock returned -11.6% (delay-adjusted); from the execution session (Feb 12 2025), -15.6%. Derived: entry at the session's open, exit at the close 20 sessions later.
Charles W Moorman (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Oracle Corporation (ORCL). Across 1 priced purchase filing, the average 21-session return was -15.6% from execution and -11.6% from disclosure (delay-adjusted; derived). The largest single filing was $948K of ORCL (5,500 sh × $172.35, as filed), executed Feb 12 2025.
Technology · Oracle Corporation offers products and services that build, run and support enterprise information technology frameworks worldwide
More Technology filings→ Insider filings, newest first→ View the original filing at www.sec.gov→